| Literature DB >> 21107754 |
Orit Kaidar-Person1, Mor Moskovitz, Tomer Charas, Wasim Alsharbati, Nissim Haim.
Abstract
Single-dose pegfilgrastim is commonly used for the prophylaxis of neutropenia in patients receiving myelotoxic chemotherapy. We report a case of a 69-year-old man who was treated with chemotherapy for small-cell lung cancer and mistakenly self-administered a 36 mg overdose of pegfilgrastim, a sixfold increase over the scheduled dose.Entities:
Mesh：
Substances：
Year: 2010 PMID： 21107754 DOI： 10.1007/s12032-010-9751-5
Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064